πŸ‡ΊπŸ‡Έ FDA
Patent

US 7727992

Gyrase inhibitors and uses thereof

granted A61KA61K31/4439A61K31/444

Quick answer

US patent 7727992 (Gyrase inhibitors and uses thereof) held by Vertex Pharmaceuticals Incorporated expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jun 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/4439, A61K31/444, A61K31/506, A61K45/06